USD 170.63
(-1.98%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 970 Million USD | -0.55% |
2022 | 975.4 Million USD | 2886.44% |
2021 | 32.66 Million USD | -4.91% |
2020 | 34.34 Million USD | 67.66% |
2019 | 20.48 Million USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | -100.0% |
2016 | 71 Thousand USD | -99.96% |
2015 | 185.14 Million USD | 47.0% |
2014 | 125.95 Million USD | 37385.12% |
2013 | 336 Thousand USD | -83.94% |
2012 | 2.09 Million USD | 1614.75% |
2011 | 122 Thousand USD | -29.07% |
2010 | 172 Thousand USD | -25.54% |
2009 | 231 Thousand USD | -62.86% |
2008 | 622 Thousand USD | -98.0% |
2007 | 31.04 Million USD | 47.52% |
2006 | 21.04 Million USD | -27.59% |
2005 | 29.06 Million USD | 0.0% |
2003 | - USD | 0.0% |
2002 | - USD | 0.0% |
1999 | 2.4 Million USD | 60.0% |
1998 | 1.5 Million USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 863.4 Million USD | -9.76% |
2024 Q1 | 956.8 Million USD | -1.36% |
2024 Q3 | 733.2 Million USD | -0.29% |
2023 Q4 | 970 Million USD | 6.58% |
2023 Q2 | 888.8 Million USD | -0.97% |
2023 Q3 | 910.1 Million USD | 2.4% |
2023 Q1 | 897.5 Million USD | -12.76% |
2023 FY | 970 Million USD | -0.55% |
2022 Q1 | 38.9 Million USD | 19.11% |
2022 Q2 | 952.7 Million USD | 2349.04% |
2022 Q3 | 983.7 Million USD | 3.25% |
2022 Q4 | 1.02 Billion USD | 4.58% |
2022 FY | 975.4 Million USD | 2886.44% |
2021 Q1 | 35.49 Million USD | 3.33% |
2021 Q4 | 32.66 Million USD | -2.85% |
2021 Q3 | 33.61 Million USD | -4.46% |
2021 FY | 32.66 Million USD | -4.91% |
2021 Q2 | 35.18 Million USD | -0.85% |
2020 Q2 | 27.16 Million USD | -0.6% |
2020 Q1 | 27.32 Million USD | 33.37% |
2020 FY | 34.34 Million USD | 67.66% |
2020 Q4 | 34.34 Million USD | 20.28% |
2020 Q3 | 28.55 Million USD | 5.14% |
2019 FY | 20.48 Million USD | 0.0% |
2019 Q1 | 21.42 Million USD | 0.0% |
2019 Q4 | 20.48 Million USD | -3.05% |
2019 Q3 | 21.13 Million USD | 0.67% |
2019 Q2 | 20.99 Million USD | -2.01% |
2018 Q4 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2017 Q1 | - USD | -100.0% |
2017 Q4 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 FY | - USD | -100.0% |
2017 Q2 | - USD | 0.0% |
2016 Q2 | 175.07 Million USD | -22.22% |
2016 FY | 71 Thousand USD | -99.96% |
2016 Q4 | 71 Thousand USD | -99.95% |
2016 Q3 | 152.5 Million USD | -12.89% |
2016 Q1 | 225.07 Million USD | 21.57% |
2015 Q4 | 185.14 Million USD | -2.65% |
2015 FY | 185.14 Million USD | 47.0% |
2015 Q1 | 125.19 Million USD | -0.6% |
2015 Q2 | 177.68 Million USD | 41.93% |
2015 Q3 | 190.18 Million USD | 7.03% |
2014 Q2 | 75.24 Million USD | 29063.18% |
2014 Q1 | 258 Thousand USD | -23.21% |
2014 FY | 125.95 Million USD | 37385.12% |
2014 Q4 | 125.95 Million USD | 0.57% |
2014 Q3 | 125.23 Million USD | 66.44% |
2013 Q1 | 353 Thousand USD | -83.13% |
2013 FY | 336 Thousand USD | -83.94% |
2013 Q4 | 336 Thousand USD | -5.35% |
2013 Q3 | 355 Thousand USD | 4.41% |
2013 Q2 | 340 Thousand USD | -3.68% |
2012 Q1 | 110 Thousand USD | -9.84% |
2012 Q4 | 2.09 Million USD | 1521.71% |
2012 Q3 | 129 Thousand USD | 32.99% |
2012 Q2 | 97 Thousand USD | -11.82% |
2012 FY | 2.09 Million USD | 1614.75% |
2011 FY | 122 Thousand USD | -29.07% |
2011 Q1 | 156 Thousand USD | -9.3% |
2011 Q2 | 146 Thousand USD | -6.41% |
2011 Q3 | 135 Thousand USD | -7.53% |
2011 Q4 | 122 Thousand USD | -9.63% |
2010 Q4 | 172 Thousand USD | -8.51% |
2010 FY | 172 Thousand USD | -25.54% |
2010 Q3 | 188 Thousand USD | -7.39% |
2010 Q1 | 216 Thousand USD | -6.49% |
2010 Q2 | 203 Thousand USD | -6.02% |
2009 FY | 231 Thousand USD | -62.86% |
2009 Q1 | 543 Thousand USD | -12.7% |
2009 Q4 | 231 Thousand USD | -44.07% |
2009 Q3 | 413 Thousand USD | -2.82% |
2009 Q2 | 425 Thousand USD | -21.73% |
2008 FY | 622 Thousand USD | -98.0% |
2008 Q2 | 932 Thousand USD | -34.92% |
2008 Q1 | 1.43 Million USD | -95.39% |
2008 Q4 | 622 Thousand USD | -17.07% |
2008 Q3 | 750 Thousand USD | -19.53% |
2007 Q3 | 34.07 Million USD | -8.03% |
2007 Q1 | 31.73 Million USD | 50.82% |
2007 Q2 | 37.05 Million USD | 16.75% |
2007 Q4 | 31.04 Million USD | -8.91% |
2007 FY | 31.04 Million USD | 47.52% |
2006 Q4 | 21.04 Million USD | 0.0% |
2006 FY | 21.04 Million USD | -27.59% |
2005 Q4 | 29.06 Million USD | 0.0% |
2005 FY | 29.06 Million USD | 0.0% |
2003 FY | - USD | 0.0% |
2002 FY | - USD | 0.0% |
1999 FY | 2.4 Million USD | 60.0% |
1998 FY | 1.5 Million USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Akoya Biosciences, Inc. | 85.7 Million USD | -1031.776% |
AngioDynamics, Inc. | 5.91 Million USD | -16301.759% |
AtriCure, Inc. | 74.49 Million USD | -1202.118% |
Avinger, Inc. | 15.39 Million USD | -6200.747% |
Azenta, Inc. | 60.43 Million USD | -1505.004% |
BioLife Solutions, Inc. | 42.69 Million USD | -2172.142% |
The Cooper Companies, Inc. | 2.56 Billion USD | 62.245% |
Daxor Corporation | 755.65 Thousand USD | -128264.778% |
Ekso Bionics Holdings, Inc. | 7.16 Million USD | -13432.366% |
Femasys Inc. | 6.7 Million USD | -14375.706% |
GlucoTrack, Inc. | 196 Thousand USD | -494797.959% |
Harvard Bioscience, Inc. | 42.77 Million USD | -2167.786% |
Hologic, Inc. | 2.53 Billion USD | 61.73% |
ICU Medical, Inc. | 1.7 Billion USD | 43.099% |
Intuitive Surgical, Inc. | 89.8 Million USD | -980.178% |
KORU Medical Systems, Inc. | 4.44 Million USD | -21721.683% |
LeMaitre Vascular, Inc. | 19.09 Million USD | -4979.864% |
Innovative Eyewear, Inc. | - USD | -Infinity% |
Innovative Eyewear, Inc. | - USD | -Infinity% |
Microbot Medical Inc. | 231 Thousand USD | -419813.42% |
Meihua International Medical Technologies Co., Ltd. | 7.33 Million USD | -13131.241% |
Merit Medical Systems, Inc. | 891.35 Million USD | -8.823% |
Nephros, Inc. | 1.83 Million USD | -52732.244% |
NovoCure Limited | 596.24 Million USD | -62.686% |
NEXGEL, Inc. | 2.79 Million USD | -34567.62% |
NEXGEL, Inc. | 2.79 Million USD | -34567.62% |
Singular Genomics Systems, Inc. | 75.28 Million USD | -1188.386% |
OraSure Technologies, Inc. | 13.5 Million USD | -7083.057% |
Pro-Dex, Inc. | 13.54 Million USD | -7060.257% |
Pulse Biosciences, Inc. | 9.14 Million USD | -10508.049% |
Predictive Oncology Inc. | 2.85 Million USD | -33853.908% |
Precision Optics Corporation, Inc. | 3.43 Million USD | -28143.151% |
QuidelOrtho Corporation | 2.61 Billion USD | 62.894% |
Repligen Corporation | 711.8 Million USD | -36.273% |
Sanara MedTech Inc. | 11.79 Million USD | -8125.839% |
STAAR Surgical Company | 35.83 Million USD | -2606.926% |
Sharps Technology, Inc. | - USD | -Infinity% |
Utah Medical Products, Inc. | 342 Thousand USD | -283525.731% |
DENTSPLY SIRONA Inc. | 2.29 Billion USD | 57.808% |
Jin Medical International Ltd. | 4.11 Million USD | -23483.759% |